LAMIVUDINE ORAL

25273 reported adverse events

Drug classes: Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking LAMIVUDINE ORAL:

# Side effect Count
0 VIROLOGIC FAILURE 1902
1 DRUG RESISTANCE 1883
2 FOETAL EXPOSURE DURING PREGNANCY 1814
3 DRUG INTERACTION 1780
4 PATHOGEN RESISTANCE 1739
5 VIRAL MUTATION IDENTIFIED 1652
6 DRUG INEFFECTIVE 1071
7 DEPRESSION 1062
8 TREATMENT FAILURE 1019
9 PYREXIA 963
See all common reactions for LAMIVUDINE ORAL

LAMIVUDINE ORAL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PINEALOBLASTOMA 74 0.7957
1 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA 101 0.7829
2 CSF HIV VIRUS IDENTIFIED 18 0.7826
3 CONGENITAL NEOPLASM 21 0.7778
4 GENOTYPE DRUG RESISTANCE TEST 33 0.6735
5 CSF HIV ESCAPE SYNDROME 83 0.6014
6 HIV VIRAEMIA 115 0.5476
7 ULTRASOUND ANTENATAL SCREEN 51 0.5312
8 VIRAL MUTATION IDENTIFIED 1652 0.4481
9 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 118 0.4245
See all enriched reactions for LAMIVUDINE ORAL